An Immunohistochemical Study on the Expression of Sex Steroid Receptors in Canine Mammary Tumors

Abstract EN

Steroid hormones are found to play a major role in the genesis and progression of mammary tumors.

The aim of this study was to immunohistochemically detect the presence of estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), and progesterone receptor (PR) and also to study the association between these markers in 29 cases of benign (11) and malignant (18) canine mammary tumors.

ERα immunostaining was noticed in only one case of carcinosarcoma specifically in the nuclei of epithelial and a few myoepithelial cells.

ERβ immunostaining was noticed in the nuclei and cytoplasm of epithelial cells and smooth muscles lining the blood vessels.

Immunoexpression of ERβ was 82% in benign tumors and 78% in malignant tumors.

PR immunostaining was expressed in the nuclei of epithelial cells in both benign and malignant tumors.

Among the 15 PR+ cases, 6 (55%) were of benign type, and 9 (50%) were of malignant type.

The most common group of hormone receptor was the ERα−/PR+/ERβ+ (46%) in benign tumors and ERα−/PR−/ERβ+ (38%) in malignant tumors.

Although there was no significant association between ERα and PR with ERβ, the findings indicated that ERβ was consistently expressed in both benign and malignant tumors, irrespective of ERα and PR status.